PROCESSES FOR THE PREPARATION OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF

PROCESSES FOR THE PREPARATION OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF

87958287 ABSTRACT Provided are processes for the preparation of enantiomerically enriched or enantiomerically pure 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine- 2,6-dione, or a pharmaceutically acceptable form thereof. Date Recue/Date Received 2021-02-11 87958287 ABRÉGÉ : I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FEIGELSON, GREGG B, TRAVERSE, JOHN F, LEONG, WILLIAM W, ZHANG, CHENGMIN, COHEN, BENJAMIN M
Format: Patent
Sprache:eng ; fre
Schlagworte:
APPARATUS THEREFOR
CHEMISTRY
GENERAL METHODS OF ORGANIC CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:87958287 ABSTRACT Provided are processes for the preparation of enantiomerically enriched or enantiomerically pure 3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine- 2,6-dione, or a pharmaceutically acceptable form thereof. Date Recue/Date Received 2021-02-11 87958287 ABRÉGÉ : Il est décrit des procédés de préparation de 3-(4-((4-(morpholinométhyl)benzyl)oxy)-1-oxoisoindolin-2-yl)pipéridine-2,6-dione énantiomériquement enrichi ou énantiomériquement pur, ou de sa forme pharmaceutiquement acceptable. Date reçue / Date Received 2021-02-11